PDX models utilize patient tumor tissue implanted into mice, thus they recapitulate intra-tumor heterogeneity seen in patients and hence provide a relevant model for testing novel cancer therapies. TCDM provides implantation of tumor tissue pieces into immunocompromised mice and subsequent follow-up on animals. The customer is expected to provide patient material for the studies.